Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia; School of Medicine and Pharmacology, The University of Western Australia, Perth, WA, Australia; Department of Gastroenterology and Hepatology, St. Vincent's Hospital, Sydney, NSW, Australia.
Clinical Studies and Epidemiology, Garvan Institute of Medical Research, Sydney, NSW, Australia.
J Steroid Biochem Mol Biol. 2019 Feb;186:110-116. doi: 10.1016/j.jsbmb.2018.10.002. Epub 2018 Oct 5.
A proportion of circulating 25-hydroxy vitamin D (25(OH)D) undergoes epimerization to form C3-epi 25(OH)D and C3-epi 1,25(OH)D. These epimers have less calcaemic activity than non-epimerized metabolites and are not differentiated by many immunoassays when reporting total 25(OH)D levels. This study aimed to compare the effect of exposure to ultraviolet radiation (UVR) and oral vitamin D supplementation on vitamin D C3-epimer levels. C57Bl/6 female mice were fed either vitamin D-sufficient (vitamin D 2000 IU/kg) or -deficient diets (no vitamin D) for 4 weeks. Among the vitamin D-deficient group, the shaved backs of half were irradiated daily for 4 days with 1 kJ/m UVR, followed by twice weekly irradiation for 4 weeks. Despite similar 25(OH)D levels, the UV-irradiated group had a lower proportion of C3-epi 25(OH)D at week 7 (p < 0.05) and week 9 (p < 0.01). C3-epimer concentrations and %C3-epi 25(OH)D were also analysed in serum samples from two human clinical trials. These trials investigated the effect of high dose oral vitamin D supplementation and narrowband UVB phototherapy, respectively. Serum 25(OH)D and the %C3-epi 25(OH)D levels measured at 12 months after oral vitamin D supplementation were not significantly different to those measured at the time of maximal effect of phototherapy (2 months). Thus, the proportion of 25(OH)D that undergoes epimerization is greater with oral vitamin D supplementation than exposure to UVR in mice, but not in humans. This important difference between human and murine vitamin D metabolism warrants consideration when interpreting animal studies.
一部分循环中的 25-羟维生素 D(25(OH)D)会发生差向异构化,形成 C3-差向 25(OH)D 和 C3-差向 1,25(OH)D。这些差向异构体的钙调节活性低于非差向异构代谢物,并且在报告总 25(OH)D 水平时,许多免疫测定方法无法区分它们。本研究旨在比较暴露于紫外线辐射(UVR)和口服维生素 D 补充对维生素 D C3-差向异构体水平的影响。C57Bl/6 雌性小鼠分别喂食维生素 D 充足(维生素 D 2000 IU/kg)或缺乏(无维生素 D)饮食 4 周。在维生素 D 缺乏组中,一半的背部被 1kJ/m UVR 照射,每天照射 4 天,然后每周照射两次,共照射 4 周。尽管 25(OH)D 水平相似,但在第 7 周(p<0.05)和第 9 周(p<0.01)时,UV 照射组的 C3-差向 25(OH)D 比例较低。在来自两项人体临床试验的血清样本中还分析了 C3-差向异构体浓度和%C3-差向 25(OH)D。这两项试验分别研究了大剂量口服维生素 D 补充和窄谱 UVB 光疗的影响。口服维生素 D 补充 12 个月后测量的血清 25(OH)D 和%C3-差向 25(OH)D 水平与光疗最大效应时(2 个月)测量的水平没有显著差异。因此,与小鼠暴露于 UVR 相比,口服维生素 D 补充后发生差向异构化的 25(OH)D 比例更高,但在人类中并非如此。这种人类和鼠类维生素 D 代谢之间的重要差异在解释动物研究时需要考虑。